Chargement en cours...
Impact of serogroup A meningococcal conjugate vaccine for Africa
The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated countries. Success must, however, not distract f...
Enregistré dans:
Publié dans: | Hum Vaccin Immunother |
---|---|
Auteur principal: | |
Format: | Artigo |
Langue: | Inglês |
Publié: |
Taylor & Francis
2018
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989890/ https://ncbi.nlm.nih.gov/pubmed/29194010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1412022 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|